[(1S,4S,10S)-4,12-diacetyloxy-1,9-dihydroxy-15-[2-hydroxy-3-(2-methylbutanoylamino)-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
159001-25-9CCC(C)C(=O)NC(c1ccccc1)C(O)C(=O)OC1C[C@@]2(O)C(OC(=O)c3ccccc3)C3[C@]4(OC(C)=O)COC4CC(O)[C@@]3(C)C(=O)C(OC(C)=O)C(=C1C)C2(C)COKEKLOJNCOIPIT-FJLPVWCPSA-N159001-25-9안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P260, P264, P270, P280, P301+P316, P318, P319, P321, P330, P405, and P501 (click each P-code to see the statement)
The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
용도Dihydrocephalomannine has been shown to reduce cytotoxicity and tubulin binding compared to Paclitaxel (P132500). Paclitaxel - Impurity R.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…